{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T08:16:38Z","timestamp":1783671398259,"version":"3.55.0"},"reference-count":187,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T00:00:00Z","timestamp":1776124800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Intramural Research Program of the National Heart, Lung, and Blood Institute"},{"name":"Intramural Research Program of the National Cancer Institute"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hematol Malig Rep"],"DOI":"10.1007\/s11899-026-00777-2","type":"journal-article","created":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T08:47:26Z","timestamp":1776156446000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clonal Signatures of Telomere Biology Disorders"],"prefix":"10.1007","volume":"21","author":[{"given":"Luca","family":"Arcuri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma M.","family":"Groarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon A.","family":"Savage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernanda","family":"Gutierrez-Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,14]]},"reference":[{"key":"777_CR1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000989","author":"S Jaiswal","year":"2020","unstructured":"Jaiswal S. Clonal hematopoiesis and nonhematologic disorders. Blood. 2020. https:\/\/doi.org\/10.1182\/blood.2019000989.","journal-title":"Blood"},{"key":"777_CR2","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022222","author":"LD Weeks","year":"2023","unstructured":"Weeks LD, Ebert BL. Causes and consequences of clonal hematopoiesis. Blood. 2023. https:\/\/doi.org\/10.1182\/blood.2023022222.","journal-title":"Blood"},{"key":"777_CR3","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019000990","author":"FD Tsai","year":"2020","unstructured":"Tsai FD, Lindsley RC. Clonal hematopoiesis in the inherited bone marrow failure syndromes. Blood. 2020. https:\/\/doi.org\/10.1182\/blood.2019000990.","journal-title":"Blood"},{"key":"777_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.beha.2021.101279","author":"F Gutierrez-Rodrigues","year":"2021","unstructured":"Gutierrez-Rodrigues F, Sahoo S, Wlodarski MW, Young NS. Somatic mosaicism in inherited bone marrow failure syndromes. Best Pract Res Clin Haematol. 2021. https:\/\/doi.org\/10.1016\/j.beha.2021.101279.","journal-title":"Best Pract Res Clin Haematol"},{"key":"777_CR5","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2024.01.005","author":"E Attardi","year":"2024","unstructured":"Attardi E, Corey SJ, Wlodarski MW. Clonal hematopoiesis in children with predisposing conditions. Semin Hematol. 2024. https:\/\/doi.org\/10.1053\/j.seminhematol.2024.01.005.","journal-title":"Semin Hematol"},{"key":"777_CR6","doi-asserted-by":"publisher","unstructured":"Schratz KE. Clonal evolution in inherited marrow failure syndromes predicts disease progression. Hematology: Am Soc Hematol Educ Program. 2023;2023(1). https:\/\/doi.org\/10.1182\/hematology.2023000469.","DOI":"10.1182\/hematology.2023000469"},{"key":"777_CR7","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2024025023","author":"F Gutierrez-Rodrigues","year":"2024","unstructured":"Gutierrez-Rodrigues F, Groarke EM, Thongon N, et al. Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescue and cancer mutations. Blood. 2024. https:\/\/doi.org\/10.1182\/blood.2024025023.","journal-title":"Blood"},{"key":"777_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-019-0139-x","author":"P Revy","year":"2019","unstructured":"Revy P, Kannengiesser C, Fischer A, Revy P, Kannengiesser C, Fischer A. Somatic genetic rescue in Mendelian haematopoietic diseases. Nature Reviews Genetics 2019 20:10. 2019. https:\/\/doi.org\/10.1038\/s41576-019-0139-x.","journal-title":"Nature Reviews Genetics 2019 20:10"},{"key":"777_CR9","unstructured":"Savage SANM. Dyskeratosis congenita and related telomere biology disorders. GeneReviews\u00ae [Internet]. 2009 [Updated 2023 Jan 19];."},{"key":"777_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41576-022-00527-z","author":"P Revy","year":"2022","unstructured":"Revy P, Kannengiesser C, Bertuch AA, Revy P, Kannengiesser C, Bertuch AA. Genetics of human telomere biology disorders. Nat Rev Genet. 2022. https:\/\/doi.org\/10.1038\/s41576-022-00527-z.","journal-title":"Nat Rev Genet"},{"key":"777_CR11","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S256425","author":"SM Mir","year":"2020","unstructured":"Mir SM, Tehrani SS, Goodarzi G, et al. Shelterin complex at telomeres: implications in ageing. Clin Interv Aging. 2020. https:\/\/doi.org\/10.2147\/CIA.S256425.","journal-title":"Clin Interv Aging"},{"key":"777_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-024-00800-5","author":"C Jones-Weinert","year":"2024","unstructured":"Jones-Weinert C, Mainz L, Karlseder J. Telomere function and regulation from mouse models to human ageing and disease. Nat Rev Mol Cell Biol. 2024. https:\/\/doi.org\/10.1038\/s41580-024-00800-5.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"777_CR13","doi-asserted-by":"publisher","unstructured":"Hamma T, Ferr\u00e9-D\u2019Amar\u00e9 AR, The box HACA, ribonucleoprotein, complex. Interplay of RNA and protein structures in post-transcriptional RNA modification. J Biol Chem. 2009;285(2). https:\/\/doi.org\/10.1074\/jbc.R109.076893.","DOI":"10.1074\/jbc.R109.076893"},{"key":"777_CR14","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19851","author":"SA Savage","year":"2024","unstructured":"Savage SA, Bertuch AA. Different phenotypes with different endings\u2014telomere biology disorders and cancer predisposition with long telomeres. Br J Haematol. 2024. https:\/\/doi.org\/10.1111\/bjh.19851.","journal-title":"Br J Haematol"},{"key":"777_CR15","doi-asserted-by":"publisher","DOI":"10.1016\/j.gde.2020.01.002","author":"E Claude","year":"2020","unstructured":"Claude E, Decottignies A. Telomere maintenance mechanisms in cancer: telomerase, ALT or lack thereof. Curr Opin Genet Dev. 2020. https:\/\/doi.org\/10.1016\/j.gde.2020.01.002.","journal-title":"Curr Opin Genet Dev"},{"key":"777_CR16","doi-asserted-by":"publisher","DOI":"10.1126\/science.aao0535","author":"K Chiba","year":"2017","unstructured":"Chiba K, Lorbeer FK, Shain AH, et al. Mutations in the promoter of the telomerase gene TERT contribute to tumorigenesis by a two-step mechanism. Science. 2017. https:\/\/doi.org\/10.1126\/science.aao0535.","journal-title":"Science"},{"key":"777_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.589929","author":"M Dratwa","year":"2020","unstructured":"Dratwa M, Wysocza\u0144ska B, \u0141acina P, Kubik T, Bogunia-Kubik K. TERT\u2014regulation and roles in cancer formation. Front Immunol. 2020. https:\/\/doi.org\/10.3389\/fimmu.2020.589929.","journal-title":"Front Immunol"},{"key":"777_CR18","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a041703","author":"S Siteni","year":"2024","unstructured":"Siteni S, Grichuk A, Shay JW. Telomerase in cancer therapeutics. Cold Spring Harb Perspect Biol. 2024. https:\/\/doi.org\/10.1101\/cshperspect.a041703.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"777_CR19","doi-asserted-by":"publisher","unstructured":"SA S. Telomeres and Human Disease - PubMed. Cold Spring Harb Perspect Biol. 2025. https:\/\/doi.org\/10.1101\/cshperspect.a041684.","DOI":"10.1101\/cshperspect.a041684"},{"key":"777_CR20","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2022-171040","author":"KB Stevens","year":"2022","unstructured":"Stevens KB, Raj HA, Carson H, Savage SA, Agarwal S. Publication of second edition telomere biology disorders: diagnosis and management guidelines. Blood. 2022. https:\/\/doi.org\/10.1182\/blood-2022-171040.","journal-title":"Blood"},{"key":"777_CR21","doi-asserted-by":"publisher","unstructured":"Catto LFB, Aggarwal N, Shalhoub R et al. Clinical and molecular features of immunodeficiency in patients with telomere biology disorders. Blood. https:\/\/doi.org\/10.1182\/blood.2024026735","DOI":"10.1182\/blood.2024026735"},{"key":"777_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109837","author":"B Rolles","year":"2023","unstructured":"Rolles B, Caballero-Oteyza A, Proietti M, et al. Telomere biology disorders may manifest as common variable immunodeficiency (CVID). Clin Immunol. 2023. https:\/\/doi.org\/10.1016\/j.clim.2023.109837.","journal-title":"Clin Immunol"},{"key":"777_CR23","doi-asserted-by":"publisher","unstructured":"W CL, H VS, T CC, et al. Short telomere syndromes cause a primary T cell immunodeficiency - PubMed. J Clin Investig. 2018;128(12). https:\/\/doi.org\/10.1172\/JCI120216.","DOI":"10.1172\/JCI120216"},{"key":"777_CR24","doi-asserted-by":"publisher","unstructured":"AJ HT. The evolving genetic landscape of telomere biology disorder dyskeratosis congenita - PubMed. EMBO Mol Med. 2024;16(10). https:\/\/doi.org\/10.1038\/s44321-024-00118-x.","DOI":"10.1038\/s44321-024-00118-x"},{"key":"777_CR25","doi-asserted-by":"crossref","unstructured":"Tometten M, Beier F, Kirschner M, et al. Late-onset telomere biology disorders in adults: clinical insights and treatment outcomes from a retrospective registry cohort. Blood Adv. 2025;13;9.","DOI":"10.1182\/bloodadvances.2024014632"},{"key":"777_CR26","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adp8093","author":"A Sanz-Moreno","year":"2025","unstructured":"Sanz-Moreno A, Becker L, Xie K, et al. Loss of Ten1 in mice induces telomere shortening and models human dyskeratosis congenita. Sci Adv. 2025. https:\/\/doi.org\/10.1126\/sciadv.adp8093.","journal-title":"Sci Adv"},{"key":"777_CR27","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-024-01722-8","author":"M Kvarnung","year":"2024","unstructured":"Kvarnung M, Pettersson M, Chun-on P, et al. Identification of biallelic POLA2 variants in two families with an autosomal recessive telomere biology disorder. Eur J Hum Genet. 2024. https:\/\/doi.org\/10.1038\/s41431-024-01722-8.","journal-title":"Eur J Hum Genet"},{"key":"777_CR28","doi-asserted-by":"publisher","unstructured":"Kochman R, Ba I, Yates M, et al. Heterozygous RPA2 variant as a novel genetic cause of telomere biology disorders. Genes Dev. 2024;38(15\u201316). https:\/\/doi.org\/10.1101\/gad.352032.124.","DOI":"10.1101\/gad.352032.124"},{"key":"777_CR29","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021013523","author":"MR Niewisch","year":"2022","unstructured":"Niewisch MR, Giri N, McReynolds LJ, et al. Disease progression and clinical outcomes in telomere biology disorders. Blood. 2022. https:\/\/doi.org\/10.1182\/blood.2021013523.","journal-title":"Blood"},{"key":"777_CR30","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2018-03-837799","author":"H Tummala","year":"2018","unstructured":"Tummala H, Collopy LC, Walne AJ. Homozygous OB-fold variants in telomere protein TPP1 are associated with dyskeratosis congenita\u2013like phenotypes. Blood. 2018. https:\/\/doi.org\/10.1182\/blood-2018-03-837799.","journal-title":"Blood"},{"key":"777_CR31","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-08-596445","author":"Y Guo","year":"2014","unstructured":"Guo Y, Kartawinata M, Li J. Inherited bone marrow failure associated with germline mutation of ACD, the gene encoding telomere protein TPP1. Blood. 2014. https:\/\/doi.org\/10.1182\/blood-2014-08-596445.","journal-title":"Blood"},{"key":"777_CR32","doi-asserted-by":"publisher","DOI":"10.1101\/gad.248567.114","author":"H Kocak","year":"2014","unstructured":"Kocak H, Ballew BJ, Bisht K. Hoyeraal-Hreidarsson syndrome caused by a germline mutation in the TEL patch of the telomere protein TPP1. Genes Dev. 2014. https:\/\/doi.org\/10.1101\/gad.248567.114.","journal-title":"Genes Dev"},{"key":"777_CR33","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00809-2019","author":"TW Hoffman","year":"2019","unstructured":"Hoffman TW, Vis J, Smagt J. Pulmonary fibrosis linked to variants in the ACD gene, encoding the telomere protein TPP1. Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.00809-2019.","journal-title":"Eur Respir J"},{"key":"777_CR34","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.24193","author":"RB Keller","year":"2012","unstructured":"Keller RB, Gagne KE, Usmani GN. CTC1 Mutations in a patient with dyskeratosis congenita. Pediatr Blood Cancer. 2012. https:\/\/doi.org\/10.1002\/pbc.24193.","journal-title":"Pediatr Blood Cancer"},{"key":"777_CR35","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2012.071068","author":"AJ Walne","year":"2013","unstructured":"Walne AJ, Bhagat T, Kirwan M. Mutations in the telomere capping complex in bone marrow failure and related syndromes. Haematologica. 2013. https:\/\/doi.org\/10.3324\/haematol.2012.071068.","journal-title":"Haematologica"},{"key":"777_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2017.09.041","author":"H Lin","year":"2017","unstructured":"Lin H, Gong L, Zhan S, Wang Y, Liu A. Novel biallelic missense mutations in CTC1 gene identified in a Chinese family with Coats plus syndrome. J Neurol Sci. 2017. https:\/\/doi.org\/10.1016\/j.jns.2017.09.041.","journal-title":"J Neurol Sci"},{"key":"777_CR37","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.495","author":"F Sargolzaeiaval","year":"2018","unstructured":"Sargolzaeiaval F, Zhang J, Schleit J. CTC 1  mutations in a Brazilian family with progeroid features and recurrent bone fractures. Mol Genet Genomic Med. 2018. https:\/\/doi.org\/10.1002\/mgg3.495.","journal-title":"Mol Genet Genomic Med"},{"key":"777_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2020.09.038","author":"RW Himes","year":"2021","unstructured":"Himes RW, Chiou EH, Queliza K, et al. Gastrointestinal hemorrhage: a manifestation of the telomere biology disorders. J Pediatr. 2021. https:\/\/doi.org\/10.1016\/j.jpeds.2020.09.038.","journal-title":"J Pediatr"},{"key":"777_CR39","doi-asserted-by":"publisher","DOI":"10.1080\/13816810.2020.1772315","author":"E Han","year":"2020","unstructured":"Han E, Patel NA, Yannuzzi NA. A unique case of coats plus syndrome and dyskeratosis congenita in a patient with CTC1 mutations. Ophthalmic Genet. 2020. https:\/\/doi.org\/10.1080\/13816810.2020.1772315.","journal-title":"Ophthalmic Genet"},{"key":"777_CR40","doi-asserted-by":"publisher","DOI":"10.1159\/000520410","author":"J Riquelme","year":"2021","unstructured":"Riquelme J, Takada S, van Dijk T. Primary Ovarian Failure in Addition to Classical Clinical Features of Coats Plus Syndrome in a Female Carrying 2 Truncating Variants of CTC1. Horm Res Paediatr. 2021. https:\/\/doi.org\/10.1159\/000520410.","journal-title":"Horm Res Paediatr"},{"key":"777_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.neurol.2015.01.566","author":"A Bisserbe","year":"2015","unstructured":"Bisserbe A, Tertian G, Buffet C, et al. Cerebro-retinal microangiopathy with calcifications and cysts due to recessive mutations in the CTC1 gene. Rev Neurol (Paris). 2015. https:\/\/doi.org\/10.1016\/j.neurol.2015.01.566.","journal-title":"Rev Neurol (Paris)"},{"issue":"1","key":"777_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-015-0151-8","volume":"16","author":"M Netravathi","year":"2015","unstructured":"Netravathi M, Kumari R, Kapoor S, et al. Whole exome sequencing in an Indian family links Coats plus syndrome and dextrocardia with a homozygous novel CTC1 and a rare HES7 variation. BMC Med Genet. 2015;16(1):5. https:\/\/doi.org\/10.1186\/s12881-015-0151-8.","journal-title":"BMC Med Genet"},{"key":"777_CR43","doi-asserted-by":"publisher","unstructured":"T J, S L, Y T, W O. [Genetic analysis of a child with gastrointestinal hemorrhage and Cerebroretinal microangiopathy with calcifications and cysts and a literature review] - PubMed. Zhonghua yi xue yi chuan xue za zhi\u2009=\u2009Zhonghua yixue yichuanxue zazhi\u2009=\u2009Chinese journal of medical genetics. 2025;42(4) https:\/\/doi.org\/10.3760\/cma.j.cn511374-20240620-00345.","DOI":"10.3760\/cma.j.cn511374-20240620-00345"},{"key":"777_CR44","doi-asserted-by":"publisher","unstructured":"L L, H L, Y S, et al. A novel mutation of CTC1 leads to telomere shortening in a chinese family with interstitial lung disease - PubMed. Hereditas 2023;160(1)https:\/\/doi.org\/10.1186\/s41065-023-00299-4","DOI":"10.1186\/s41065-023-00299-4"},{"key":"777_CR45","doi-asserted-by":"publisher","unstructured":"L K, D C, A A, et al. Inherited human Apollo deficiency causes severe bone marrow failure and developmental defects - PubMed. Blood 2022;139(16). https:\/\/doi.org\/10.1182\/blood.2021010791.","DOI":"10.1182\/blood.2021010791"},{"key":"777_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.07.025","author":"V Gaysinskaya","year":"2020","unstructured":"Gaysinskaya V, Stanley SE, Adam S, Armanios M. Synonymous mutation in DKC1 causes telomerase RNA insufficiency manifesting as familial pulmonary fibrosis. Chest. 2020. https:\/\/doi.org\/10.1016\/j.chest.2020.07.025.","journal-title":"Chest"},{"key":"777_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/ng0598-32","author":"NS Heiss","year":"1998","unstructured":"Heiss NS, Knight SW, Vulliamy TJ, et al. X-linked dyskeratosis congenita is caused by mutations in a highly conserved gene with putative nucleolar functions. Nature Genetics 1998 19:1. 1998. https:\/\/doi.org\/10.1038\/ng0598-32.","journal-title":"Nature Genetics 1998 19:1"},{"key":"777_CR48","doi-asserted-by":"publisher","DOI":"10.1086\/302446","author":"SW Knight","year":"1999","unstructured":"Knight SW, Heiss NS, Vulliamy TJ, et al. X-linked dyskeratosis congenita is predominantly caused by missense mutations in the DKC1 gene. Am J Hum Genet. 1999. https:\/\/doi.org\/10.1086\/302446.","journal-title":"Am J Hum Genet"},{"key":"777_CR49","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-07-2622","author":"TJ Vulliamy","year":"2006","unstructured":"Vulliamy TJ, Marrone A, Knight SW, Walne A, Mason PJ, Dokal I. Mutations in dyskeratosis congenita: their impact on telomere length and the diversity of clinical presentation. Blood. 2006. https:\/\/doi.org\/10.1182\/blood-2005-07-2622.","journal-title":"Blood"},{"key":"777_CR50","doi-asserted-by":"publisher","unstructured":"Vulliamy TJ, Knight SW, Heiss NS et al. Dyskeratosis congenita caused by a 3\u2032 Deletion: Germline and Somatic Mosaicism in a Female Carrier. Blood. 1999;94(4)https:\/\/doi.org\/10.1182\/blood.V94.4.1254","DOI":"10.1182\/blood.V94.4.1254"},{"key":"777_CR51","doi-asserted-by":"publisher","DOI":"10.1007\/s004390100494","author":"S Knight","year":"2001","unstructured":"Knight S, Vulliamy T, Morgan B, et al. Identification of novel DKC1 mutations in patients with dyskeratosis congenita: implications for pathophysiology and diagnosis. Hum Genet. 2001. https:\/\/doi.org\/10.1007\/s004390100494.","journal-title":"Hum Genet"},{"key":"777_CR52","doi-asserted-by":"publisher","unstructured":"Hiramatsu H, Fujii T, Kitoh T, A novel missense mutation in the dkc1 gene in a japanese family with x-linked dyskeratosis congenita, et al. Pediatr Hematol Oncol. 2002;1\u20131(6). https:\/\/doi.org\/10.1080\/08880010290097170.","DOI":"10.1080\/08880010290097170"},{"key":"777_CR53","doi-asserted-by":"publisher","unstructured":"Kanegane H, Kasahara Y, Okamura J et al. Identification of DKC1 gene mutations in Japanese patients with X-linked dyskeratosis congenita. Br J Haematol. 2005;129(3). https:\/\/doi.org\/10.1111\/j.1365-2141.2005.05473.x","DOI":"10.1111\/j.1365-2141.2005.05473.x"},{"key":"777_CR54","doi-asserted-by":"publisher","unstructured":"Ding Y-g, Zhu T-s, Jiang W et al. Identification of a novel mutation and a de novo mutation in DKC1 in two chinese pedigrees with dyskeratosis congenita. J Invest Dermatology. 2004;123(3)https:\/\/doi.org\/10.1111\/j.0022-202X.2004.23228.x","DOI":"10.1111\/j.0022-202X.2004.23228.x"},{"key":"777_CR55","doi-asserted-by":"publisher","unstructured":"Ratnasamy V, Navaneethakrishnan S, Sirisena ND et al. Dyskeratosis congenita with a novel genetic variant in the DKC1 gene: a case report. BMC Medical Genetics 2018 19:1. 2018;19(1)https:\/\/doi.org\/10.1186\/s12881-018-0584-y","DOI":"10.1186\/s12881-018-0584-y"},{"key":"777_CR56","doi-asserted-by":"publisher","unstructured":"Vulliamy TJ, Kirwan MJ, Beswick R, et al. Differences in disease severity but similar telomere lengths in genetic subgroups of patients with telomerase and shelterin mutations. PLoS ONE. 2011;13(9). https:\/\/doi.org\/10.1371\/journal.pone.0024383.","DOI":"10.1371\/journal.pone.0024383"},{"key":"777_CR57","doi-asserted-by":"publisher","unstructured":"Kropski JA, Mitchell DB, Markin C et al. A Novel Dyskerin (DKC1) Mutation Is Associated With Familial Interstitial Pneumonia. Chest. 2014;146(1). https:\/\/doi.org\/10.1378\/chest.13-2224","DOI":"10.1378\/chest.13-2224"},{"key":"777_CR58","doi-asserted-by":"publisher","DOI":"10.1007\/s00431-003-1317-5","author":"Y Sznajer","year":"2003","unstructured":"Sznajer Y, Baumann C, David A, et al. Further delineation of the congenital form of X-linked dyskeratosis congenita (Hoyeraal-Hreidarsson syndrome). Eur J Pediatr. 2003. https:\/\/doi.org\/10.1007\/s00431-003-1317-5.","journal-title":"Eur J Pediatr"},{"key":"777_CR59","doi-asserted-by":"publisher","unstructured":"Cossu F, Vulliamy TJ, Marrone A, Badiali M, Cao A, Dokal I. A novel DKC1 mutation, severe combined immunodeficiency (T\u2009+\u2009B\u2013NK\u2013 SCID) and bone marrow transplantation in an infant with Hoyeraal\u2013Hreidarsson syndrome. Br J Haematol. 2002;01;119. https:\/\/doi.org\/10.1046\/j.1365-2141.2002.03822.x","DOI":"10.1046\/j.1365-2141.2002.03822.x"},{"key":"777_CR60","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1999.01690.x","author":"SW Knight","year":"1999","unstructured":"Knight SW, Heiss NS, Vulliamy TJ, et al. Unexplained aplastic anaemia, immunodeficiency, and cerebellar hypoplasia (Hoyeraal-Hreidarsson syndrome) due to mutations in the dyskeratosis congenita gene, DKC1. Br J Haematol. 1999. https:\/\/doi.org\/10.1046\/j.1365-2141.1999.01690.x.","journal-title":"Br J Haematol"},{"key":"777_CR61","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aaf7837","author":"SE Stanley","year":"2016","unstructured":"Stanley SE, Gable DL, Wagner CL, et al. Loss-of-function mutations in the RNA biogenesis factor NAF1 predispose to pulmonary fibrosis\u2013emphysema. Sci Transl Med. 2016. https:\/\/doi.org\/10.1126\/scitranslmed.aaf7837.","journal-title":"Sci Transl Med"},{"key":"777_CR62","doi-asserted-by":"publisher","unstructured":"A A-G, I V-F, E T-H, et al. A tiered strategy to identify relevant genetic variants in familial pulmonary fibrosis: a proof of concept for the clinical practice - PubMed. Eur J Hum genetics: EJHG. 2025;33(11). https:\/\/doi.org\/10.1038\/s41431-024-01772-y.","DOI":"10.1038\/s41431-024-01772-y"},{"key":"777_CR63","doi-asserted-by":"publisher","unstructured":"Galtier J, Dimicoli-Salazar S, Trimouille A et al. First clinical description of a pedigree with complete NAF1 deletion. Leuk Lymphoma. 2023;64(2)https:\/\/doi.org\/10.1080\/10428194.2022.2148377","DOI":"10.1080\/10428194.2022.2148377"},{"key":"777_CR64","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddaa011","author":"M Benyelles","year":"2020","unstructured":"Benyelles M, O\u2019Donohue M-F, Kermasson L, et al. NHP2 deficiency impairs rRNA biogenesis and causes pulmonary fibrosis and H\u00f8yeraal\u2013Hreidarsson syndrome. Hum Mol Genet. 2020. https:\/\/doi.org\/10.1093\/hmg\/ddaa011.","journal-title":"Hum Mol Genet"},{"key":"777_CR65","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0800042105","author":"T Vulliamy","year":"2008","unstructured":"Vulliamy T, Beswick R, Kirwan M, et al. Mutations in the telomerase component NHP2 cause the premature ageing syndrome dyskeratosis congenita. Proc Natl Acad Sci U S A. 2008. https:\/\/doi.org\/10.1073\/pnas.0800042105.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"777_CR66","doi-asserted-by":"publisher","unstructured":"\u0130 SK DD. G B, Siblings with a Homozygous Variant in the NHP2 GenE: a case report and review of literature - PubMed. Mol Syndromol.\u00a02024.\u00a0https:\/\/doi.org\/10.1159\/000543315","DOI":"10.1159\/000543315"},{"key":"777_CR67","doi-asserted-by":"publisher","DOI":"10.1159\/000494421","author":"M Erdem","year":"2019","unstructured":"Erdem M, T\u00fcfek\u00e7i \u00d6, Y\u0131lmaz \u015e, Alacac\u0131o\u011flu \u0130, \u00d6ren H. Long-term follow-up of a case with dyskeratosis congenita caused by NHP2-V126M\/X154R mutation: genotype-phenotype association. Acta Haematol. 2019. https:\/\/doi.org\/10.1159\/000494421.","journal-title":"Acta Haematol"},{"key":"777_CR68","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddm111","author":"AJ Walne","year":"2007","unstructured":"Walne AJ, Vulliamy T, Marrone A. Genetic heterogeneity in autosomal recessive dyskeratosis congenita with one subtype due to mutations in the telomerase-associated protein NOP10. Hum Mol Genet. 2007. https:\/\/doi.org\/10.1093\/hmg\/ddm111.","journal-title":"Hum Mol Genet"},{"key":"777_CR69","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02465-2019","author":"C Kannengiesser","year":"2020","unstructured":"Kannengiesser C, Manali ED, Revy P, et al. First heterozygous NOP10 mutation in familial pulmonary fibrosis. Eur Respir J. 2020. https:\/\/doi.org\/10.1183\/13993003.02465-2019.","journal-title":"Eur Respir J"},{"key":"777_CR70","doi-asserted-by":"publisher","unstructured":"LM D. From incomplete penetrance with normal telomere length to severe disease and telomere shortening in a family with monoallelic and biallelic PARN pathogenic variants - PubMed. Hum Mutat. 2019;40(12). https:\/\/doi.org\/10.1002\/humu.23898.","DOI":"10.1002\/humu.23898"},{"key":"777_CR71","doi-asserted-by":"publisher","DOI":"10.1172\/JCI78963","author":"H Tummala","year":"2015","unstructured":"Tummala H, Walne A, Collopy L, et al. Poly(A)-specific ribonuclease deficiency impacts telomere biology and causes dyskeratosis congenita. J Clin Invest. 2015. https:\/\/doi.org\/10.1172\/JCI78963.","journal-title":"J Clin Invest"},{"key":"777_CR72","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2015.12.005","author":"AM Burris","year":"2016","unstructured":"Burris AM, Ballew BJ, Kentosh JB, Turner CE, Norton SA. Hoyeraal-hreidarsson syndrome due to PARN mutations: fourteen years of follow-up. Pediatr Neurol. 2016. https:\/\/doi.org\/10.1016\/j.pediatrneurol.2015.12.005.","journal-title":"Pediatr Neurol"},{"key":"777_CR73","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201809-1632LE","author":"D Zhang","year":"2019","unstructured":"Zhang D, Zhou Z, Abu-Hijleh M, Batra K, Xing C, Garcia CK. Homozygous rare PARN missense mutation in familial pulmonary fibrosis. Am J Respir Crit Care Med. 2019. https:\/\/doi.org\/10.1164\/rccm.201809-1632LE.","journal-title":"Am J Respir Crit Care Med"},{"key":"777_CR74","doi-asserted-by":"publisher","unstructured":"HC C, CY AN, JA L. M, CK H. Hoyeraal-Hreidarsson syndrome associated with a new homozygous splice variant in PARN - PubMed. Clin Exp Dermatol.\u00a02024;49(10).\u00a0https:\/\/doi.org\/10.1093\/ced\/llae211","DOI":"10.1093\/ced\/llae211"},{"key":"777_CR75","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000002661","author":"M\u00c7 \u015e \u00c7K","year":"2012","unstructured":"\u015e \u00c7K M\u00c7, B Y-K. Hoyeraal-Hreidarsson syndrome: a case report of dyskeratosis congenita with a novel PARN gene mutation - PubMed. Annals Med Surg (2012). https:\/\/doi.org\/10.1097\/MS9.0000000000002661.","journal-title":"Annals Med Surg"},{"key":"777_CR76","doi-asserted-by":"publisher","DOI":"10.1038\/ng.3278","author":"BD Stuart","year":"2015","unstructured":"Stuart BD, Choi J, Zaidi S, et al. Exome sequencing links mutations in PARN and RTEL1 with familial pulmonary fibrosis and telomere shortening. Nature Genetics 2015 47:5. 2015. https:\/\/doi.org\/10.1038\/ng.3278.","journal-title":"Nature Genetics 2015 47:5"},{"key":"777_CR77","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02314-2016","author":"P-A Juge","year":"2017","unstructured":"Juge P-A, Borie R, Kannengiesser C, et al. Shared genetic predisposition in rheumatoid arthritis-interstitial lung disease and familial pulmonary fibrosis. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.02314-2016.","journal-title":"Eur Respir J"},{"key":"777_CR78","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00308-2016","author":"CA Newton","year":"2016","unstructured":"Newton CA, Batra K, Torrealba J, et al. Telomere-related lung fibrosis is diagnostically heterogeneous but uniformly progressive. Eur Respir J. 2016. https:\/\/doi.org\/10.1183\/13993003.00308-2016.","journal-title":"Eur Respir J"},{"key":"777_CR79","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2015-103685","author":"C Xing","year":"2016","unstructured":"Xing C, Garcia CK. Epigenetic inheritance of telomere length obscures identification of causative PARN locus. J Med Genet. 2016. https:\/\/doi.org\/10.1136\/jmedgenet-2015-103685.","journal-title":"J Med Genet"},{"key":"777_CR80","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2020001721","author":"S Feurstein","year":"2020","unstructured":"Feurstein S, Adegunsoye A, Mojsilovic D, et al. Telomere biology disorder prevalence and phenotypes in adults with familial hematologic and\/or pulmonary presentations. Blood Adv. 2020. https:\/\/doi.org\/10.1182\/bloodadvances.2020001721.","journal-title":"Blood Adv"},{"key":"777_CR81","doi-asserted-by":"publisher","unstructured":"Q P, C K. Interstitial lung diseases associated with mutations of poly(A)-specific ribonuclease: a multicentre retrospective study - PubMed. Respirol (Carlton Vic). 2022;27(3). https:\/\/doi.org\/10.1111\/resp.14195.","DOI":"10.1111\/resp.14195"},{"key":"777_CR82","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201703-0635LE","author":"JA Kropski","year":"2017","unstructured":"Kropski JA, Reiss S, Markin C, et al. Rare genetic variants in PARN are associated with pulmonary fibrosis in families. Am J Respir Crit Care Med. 2017. https:\/\/doi.org\/10.1164\/rccm.201703-0635LE.","journal-title":"Am J Respir Crit Care Med"},{"key":"777_CR83","doi-asserted-by":"publisher","DOI":"10.1101\/gad.276873.115","author":"H Takai","year":"2016","unstructured":"Takai H, Jenkinson E, Kabir S, et al. A POT1 mutation implicates defective telomere end fill-in and telomere truncations in Coats plus. Genes & Development. 2016. https:\/\/doi.org\/10.1101\/gad.276873.115.","journal-title":"Genes & Development"},{"key":"777_CR84","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20211681","author":"J Kelich","year":"2022","unstructured":"Kelich J, Aramburu T, van der Vis JJ, et al. Telomere dysfunction implicates POT1 in patients with idiopathic pulmonary fibrosis. J Exp Med. 2022. https:\/\/doi.org\/10.1084\/jem.20211681.","journal-title":"J Exp Med"},{"key":"777_CR85","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2021011980","author":"R Sharma","year":"2022","unstructured":"Sharma R, Sahoo SS, Honda M, et al. Gain-of-function mutations in RPA1 cause a syndrome with short telomeres and somatic genetic rescue. Blood. 2022. https:\/\/doi.org\/10.1182\/blood.2021011980.","journal-title":"Blood"},{"key":"777_CR86","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2013.02.001","author":"J Walne Amanda","year":"2013","unstructured":"Walne Amanda J, Vulliamy T, Kirwan M, Plagnol V, Dokal I. Constitutional Mutations in RTEL1 Cause Severe Dyskeratosis Congenita. Am J Hum Genet. 2013. https:\/\/doi.org\/10.1016\/j.ajhg.2013.02.001.","journal-title":"Am J Hum Genet"},{"key":"777_CR87","doi-asserted-by":"publisher","unstructured":"Deng Z, Glousker G, Molczan A et al. Inherited mutations in the helicase RTEL1 cause telomere dysfunction and Hoyeraal\u2013Hreidarsson syndrome. Proceedings of the National Academy of Sciences. 2013;110(36)doi:https:\/\/doi.org\/10.1073\/pnas.1300600110","DOI":"10.1073\/pnas.1300600110"},{"key":"777_CR88","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddt178","author":"T Le Guen","year":"2013","unstructured":"Le Guen T, Jullien L, Touzot F, et al. Human RTEL1 deficiency causes Hoyeraal\u2013Hreidarsson syndrome with short telomeres and genome instability. Hum Mol Genet. 2013. https:\/\/doi.org\/10.1093\/hmg\/ddt178.","journal-title":"Hum Mol Genet"},{"key":"777_CR89","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pgen.1003695","author":"BJ Ballew","year":"2013","unstructured":"Ballew BJ, Joseph V, De S, et al. A recessive founder mutation in regulator of telomere elongation helicase 1, RTEL1, underlies severe immunodeficiency and features of Hoyeraal Hreidarsson syndrome. PLoS Genet. 2013. https:\/\/doi.org\/10.1371\/journal.pgen.1003695.","journal-title":"PLoS Genet"},{"key":"777_CR90","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-013-1265-8","author":"BJ Ballew","year":"2013","unstructured":"Ballew BJ, Yeager M, Jacobs K, et al. Germline mutations of regulator of telomere elongation helicase 1, RTEL1, in Dyskeratosis congenita. Human Genetics 2013 132:4. 2013. https:\/\/doi.org\/10.1007\/s00439-013-1265-8.","journal-title":"Human Genetics 2013 132:4"},{"key":"777_CR91","doi-asserted-by":"publisher","unstructured":"C LJ. Mutations of the RTEL1 Helicase in a hoyeraal-hreidarsson syndrome patient highlight the importance of the ARCH Domain - PubMed. Hum Mutat. 2016;37(5). https:\/\/doi.org\/10.1002\/humu.22966.","DOI":"10.1002\/humu.22966"},{"key":"777_CR92","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2016001313","author":"F Touzot","year":"2016","unstructured":"Touzot F, Kermasson L, Jullien L, et al. Extended clinical and genetic spectrum associated with biallelic RTEL1 mutations. Blood Adv. 2016. https:\/\/doi.org\/10.1182\/bloodadvances.2016001313.","journal-title":"Blood Adv"},{"key":"777_CR93","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2017.00449","author":"C Speckmann","year":"2017","unstructured":"Speckmann C, Sahoo SS, Rizzi M, et al. Frontiers | Clinical and Molecular Heterogeneity of RTEL1 Deficiency. Front Immunol. 2017. https:\/\/doi.org\/10.3389\/fimmu.2017.00449.","journal-title":"Front Immunol"},{"key":"777_CR94","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2017008110","author":"JCW Marsh","year":"2018","unstructured":"Marsh JCW, Gutierrez-Rodrigues F, Cooper J, et al. Heterozygous RTEL1 variants in bone marrow failure and myeloid neoplasms. Blood Adv. 2018. https:\/\/doi.org\/10.1182\/bloodadvances.2017008110.","journal-title":"Blood Adv"},{"key":"777_CR95","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.167056","author":"SR Cardoso","year":"2017","unstructured":"Cardoso SR, Ellison ACM, Walne AJ, et al. Myelodysplasia and liver disease extend the spectrum of RTEL1 related telomeropathies. Haematologica. 2017. https:\/\/doi.org\/10.3324\/haematol.2017.167056.","journal-title":"Haematologica"},{"key":"777_CR96","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.26030","author":"K Moriya","year":"2016","unstructured":"Moriya K, Niizuma H, Rikiishi T, Yamaguchi H, Sasahara Y, Kure S. Novel compound heterozygous RTEL1 gene mutations in a patient with Hoyeraal-Hreidarsson syndrome. Pediatr Blood Cancer. 2016. https:\/\/doi.org\/10.1002\/pbc.26030.","journal-title":"Pediatr Blood Cancer"},{"key":"777_CR97","doi-asserted-by":"publisher","unstructured":"H N, QUN MK. C, R I, T G. Case report: A novel mutation in RTEL1 gene in dyskeratosis congenita - PubMed. Front Oncol. 2023https:\/\/doi.org\/10.3389\/fonc.2023.1098876","DOI":"10.3389\/fonc.2023.1098876"},{"key":"777_CR98","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201408-1510OC","author":"JD Cogan","year":"2015","unstructured":"Cogan JD, Kropski JA, Zhao M, et al. Rare variants in RTEL1 are associated with familial interstitial pneumonia. Am J Respir Crit Care Med. 2015. https:\/\/doi.org\/10.1164\/rccm.201408-1510OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"777_CR99","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00040115","author":"C Kannengiesser","year":"2015","unstructured":"Kannengiesser C, Borie R, M\u00e9nard C, et al. Heterozygous RTEL1 mutations are associated with familial pulmonary fibrosis. Eur Respir J. 2015. https:\/\/doi.org\/10.1183\/09031936.00040115.","journal-title":"Eur Respir J"},{"key":"777_CR100","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00508-2018","author":"R Borie","year":"2019","unstructured":"Borie R, Bouvry D, Cottin V, et al. Regulator of telomere length 1 (RTEL1) mutations are associated with heterogeneous pulmonary and extra-pulmonary phenotypes. Eur Respir J. 2019. https:\/\/doi.org\/10.1183\/13993003.00508-2018.","journal-title":"Eur Respir J"},{"key":"777_CR101","doi-asserted-by":"publisher","unstructured":"G F, F B, F A, et al. A novel RTEL1 nonsense variant in a case of familial pulmonary fibrosis: clinical description and genetic implications - PubMed. BMC Pulm Med. 2025;25(1). https:\/\/doi.org\/10.1186\/s12890-025-03976-4","DOI":"10.1186\/s12890-025-03976-4"},{"key":"777_CR102","doi-asserted-by":"publisher","unstructured":"CF LL, CY H, JY W, LL LHP. Whole exome sequencing identified three novel mutations of RTEL1 in Chinese patients with idiopathic pulmonary fibrosis - PubMed. Biochim et Biophys acta Mol basis disease. 2025;1871(7). https:\/\/doi.org\/10.1016\/j.bbadis.2025.167924.","DOI":"10.1016\/j.bbadis.2025.167924"},{"key":"777_CR103","doi-asserted-by":"publisher","first-page":"1323","DOI":"10.1007\/s00439-019-02076-8","volume":"138","author":"F Gutierrez-Rodrigues","year":"2019","unstructured":"Gutierrez-Rodrigues F, Masri N, Chouery E, Diamond C, Jalkh N, Vicente A, Kajigaya S, Abillama F, Bejjani N, Serhal W, Calado RT, Young NS, Farhat H, Coussa ML. A novel homozygous RTEL1 variant in a consanguineous Lebanese family: phenotypic heterogeneity and disease anticipation. Hum Genet. 2019;138:1323\u201330. https:\/\/doi.org\/10.1007\/s00439-019-02076-8","journal-title":"Hum Genet"},{"key":"777_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(18)30135-8","author":"A Dressen","year":"2018","unstructured":"Dressen A, Abbas AR, Cabanski C, et al. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study. Lancet Respir Med. 2018. https:\/\/doi.org\/10.1016\/S2213-2600(18)30135-8.","journal-title":"Lancet Respir Med"},{"key":"777_CR105","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20151618","author":"AJ Simon","year":"2016","unstructured":"Simon AJ, Lev A, Zhang Y, et al. Mutations in STN1 cause Coats plus syndrome and are associated with genomic and telomere defects. J Exp Med. 2016. https:\/\/doi.org\/10.1084\/jem.20151618.","journal-title":"J Exp Med"},{"key":"777_CR106","doi-asserted-by":"publisher","DOI":"10.1002\/ajmg.a.61737","author":"GR Passi","year":"2020","unstructured":"Passi GR, Shamim U, Rathore S, et al. An Indian child with Coats plus syndrome due to mutations in STN1. Am J Med Genet A. 2020. https:\/\/doi.org\/10.1002\/ajmg.a.61737.","journal-title":"Am J Med Genet A"},{"key":"777_CR107","doi-asserted-by":"publisher","DOI":"10.1002\/mgg3.1708","author":"T Acharya","year":"2021","unstructured":"Acharya T, Firth HV, Dugar S, et al. Novel compound heterozygous STN1 variants are associated with Coats Plus syndrome. Mol Genet Genomic Med. 2021. https:\/\/doi.org\/10.1002\/mgg3.1708.","journal-title":"Mol Genet Genomic Med"},{"key":"777_CR108","doi-asserted-by":"publisher","unstructured":"M K. Successful liver transplantation for coats plus syndrome with hepatopulmonary syndrome: a case report and literature review - PubMed. Pediatr Transplant. 2025;29(7). https:\/\/doi.org\/10.1111\/petr.70184.","DOI":"10.1111\/petr.70184"},{"key":"777_CR109","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-03-633388","author":"LC Collopy","year":"2015","unstructured":"Collopy LC, Walne AJ, Cardoso S, et al. Triallelic and epigenetic-like inheritance in human disorders of telomerase. Blood. 2015. https:\/\/doi.org\/10.1182\/blood-2015-03-633388.","journal-title":"Blood"},{"key":"777_CR110","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0247","author":"H Ly","year":"2005","unstructured":"Ly H, Schertzer M, Jastaniah W. Identification and functional characterization of 2 variant alleles of the telomerase RNA template gene (TERC) in a patient with dyskeratosis congenita. Blood. 2005. https:\/\/doi.org\/10.1182\/blood-2005-01-0247.","journal-title":"Blood"},{"key":"777_CR111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2012.01.004","author":"MC Jongmans","year":"2012","unstructured":"Jongmans MC, Verwiel ET, Heijdra Y, et al. Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita. Am J Hum Genet. 2012. https:\/\/doi.org\/10.1016\/j.ajhg.2012.01.004.","journal-title":"Am J Hum Genet"},{"key":"777_CR112","doi-asserted-by":"publisher","DOI":"10.1038\/35096585","author":"T Vulliamy","year":"2001","unstructured":"Vulliamy T, Marrone A, Goldman F, et al. The RNA component of telomerase is mutated in autosomal dominant dyskeratosis congenita. Nature. 2001. https:\/\/doi.org\/10.1038\/35096585.","journal-title":"Nature"},{"key":"777_CR113","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa066157","author":"MY Armanios","year":"2007","unstructured":"Armanios MY, Chen J-L, Cogan JD, et al. Telomerase mutations in families with idiopathic pulmonary fibrosis. N Engl J Med. 2007. https:\/\/doi.org\/10.1056\/NEJMoa066157.","journal-title":"N Engl J Med"},{"key":"777_CR114","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0701009104","author":"KD Tsakiri","year":"2007","unstructured":"Tsakiri KD, Cronkhite JT, Kuan PJ, et al. Adult-onset pulmonary fibrosis caused by mutations in telomerase. Proc Natl Acad Sci USA. 2007. https:\/\/doi.org\/10.1073\/pnas.0701009104.","journal-title":"Proc Natl Acad Sci USA"},{"key":"777_CR115","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-018-0112-8","author":"A Norberg","year":"2018","unstructured":"Norberg A, Ros\u00e9n A, Raaschou-Jensen K, et al. Novel variants in Nordic patients referred for genetic testing of telomere-related disorders. Eur J Hum Genet. 2018. https:\/\/doi.org\/10.1038\/s41431-018-0112-8.","journal-title":"Eur J Hum Genet"},{"key":"777_CR116","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-07-166421","author":"H-Y Du","year":"2009","unstructured":"Du H-Y, Pumbo E, Ivanovich J, et al. TERC and TERT gene mutations in patients with bone marrow failure and the significance of telomere length measurements. Blood. 2009. https:\/\/doi.org\/10.1182\/blood-2008-07-166421.","journal-title":"Blood"},{"key":"777_CR117","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(03)14797-6","author":"PF Fogarty","year":"2003","unstructured":"Fogarty PF, Yamaguchi H, Wiestner A, et al. Late presentation of dyskeratosis congenita as apparently acquired aplastic anaemia due to mutations in telomerase RNA. Lancet. 2003. https:\/\/doi.org\/10.1016\/S0140-6736(03)14797-6.","journal-title":"Lancet"},{"key":"777_CR118","doi-asserted-by":"publisher","unstructured":"L RB. Prevalence and characteristics of TERT and TERC mutations in suspected genetic pulmonary fibrosis - PubMed. Eur Respir J. 2016;48(6). https:\/\/doi.org\/10.1183\/13993003.02115-2015.","DOI":"10.1183\/13993003.02115-2015"},{"key":"777_CR119","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-11-322149","author":"EM Parry","year":"2011","unstructured":"Parry EM, Alder JK, Qi X, Chen J-L, Armanios M. Syndrome complex of bone marrow failure and pulmonary fibrosis predicts germline defects in telomerase. Blood. 2011. https:\/\/doi.org\/10.1182\/blood-2010-11-322149.","journal-title":"Blood"},{"key":"777_CR120","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0007926","author":"RT Calado","year":"2009","unstructured":"Calado RT, Regal JA, Kleiner DE, et al. A spectrum of severe familial liver disorders associate with telomerase mutations. PLoS One. 2009. https:\/\/doi.org\/10.1371\/journal.pone.0007926.","journal-title":"PLoS One"},{"key":"777_CR121","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-04-710160","author":"B Boyraz","year":"2016","unstructured":"Boyraz B, Bellomo CM, Fleming MD, Cutler CS, Agarwal S. A novel TERC CR4\/CR5 domain mutation causes telomere disease via decreased TERT binding. Blood. 2016. https:\/\/doi.org\/10.1182\/blood-2016-04-710160.","journal-title":"Blood"},{"key":"777_CR122","doi-asserted-by":"publisher","DOI":"10.1002\/hep.24217","author":"D Hartmann","year":"2011","unstructured":"Hartmann D, Srivastava U, Thaler M, et al. Telomerase gene mutations are associated with cirrhosis formation. Hepatology. 2011. https:\/\/doi.org\/10.1002\/hep.24217.","journal-title":"Hepatology"},{"key":"777_CR123","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2350-15-68","author":"Y Ueda","year":"2014","unstructured":"Ueda Y, Calado RT, Norberg A, et al. A mutation in the H\/ACA box of telomerase RNA component gene (TERC) in a young patient with myelodysplastic syndrome. BMC Med Genet. 2014. https:\/\/doi.org\/10.1186\/1471-2350-15-68.","journal-title":"BMC Med Genet"},{"key":"777_CR124","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2004-09-3659","author":"H Ly","year":"2005","unstructured":"Ly H, Calado RT, Allard P, et al. Functional characterization of telomerase RNA variants found in patients with hematologic disorders. Blood. 2005. https:\/\/doi.org\/10.1182\/blood-2004-09-3659.","journal-title":"Blood"},{"key":"777_CR125","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-08-447755","author":"MM Gramatges","year":"2013","unstructured":"Gramatges MM, Qi X, Sasa GS, Chen JJ-L, Bertuch AA. A homozygous telomerase T-motif variant resulting in markedly reduced repeat addition processivity in siblings with Hoyeraal Hreidarsson syndrome. Blood. 2013. https:\/\/doi.org\/10.1182\/blood-2012-08-447755.","journal-title":"Blood"},{"key":"777_CR126","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2022007029","author":"A Niaz","year":"2022","unstructured":"Niaz A, Truong J, Manoleras A, et al. Functional interaction between compound heterozygous TERT mutations causes severe telomere biology disorder. Blood Adv. 2022. https:\/\/doi.org\/10.1182\/bloodadvances.2022007029.","journal-title":"Blood Adv"},{"key":"777_CR127","doi-asserted-by":"publisher","unstructured":"\u00c7epni E, Satk\u0131n NB, Moheb LA, Rocha ME, Kayserili H. Biallelic TERT variant leads to Hoyeraal\u2013Hreidarsson syndrome with additional dyskeratosis congenita findings. Am J Med Genet Part A. 2022;01;188. https:\/\/doi.org\/10.1002\/ajmg.a.62602","DOI":"10.1002\/ajmg.a.62602"},{"key":"777_CR128","doi-asserted-by":"publisher","DOI":"10.18632\/aging.100835","author":"C Stockklausner","year":"2015","unstructured":"Stockklausner C, Raffel S, Klermund J, et al. A novel autosomal recessive TERT T1129P mutation in a dyskeratosis congenita family leads to cellular senescence and loss of CD34\u2009+\u2009hematopoietic stem cells not reversible by mTOR-inhibition. Aging. 2015. https:\/\/doi.org\/10.18632\/aging.100835.","journal-title":"Aging"},{"key":"777_CR129","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-12-062851","author":"A Marrone","year":"2007","unstructured":"Marrone A, Walne A, Tamary H, et al. Telomerase reverse-transcriptase homozygous mutations in autosomal recessive dyskeratosis congenita and Hoyeraal-Hreidarsson syndrome. Blood. 2007. https:\/\/doi.org\/10.1182\/blood-2006-12-062851.","journal-title":"Blood"},{"key":"777_CR130","doi-asserted-by":"crossref","unstructured":"Vogiatzi P, Perdigones N, Mason PJ, Wilson DB, Bessler M. A family with Hoyeraal\u2013Hreidarsson syndrome and four variants in two genes of the telomerase core complex. Pediatr Blood Cancer. 2013;6\/06\/01;60.\u00a01002\/pbc.24389","DOI":"10.1002\/pbc.24389"},{"key":"777_CR131","doi-asserted-by":"publisher","DOI":"10.1038\/s41525-025-00501-8","author":"K Andrade","year":"2025","unstructured":"Andrade K, Pinto EM, Zhao T, et al. TERT c.3150 G\u2009>\u2009C (p.K1050N): a founder Ashkenazi Jewish variant associated with telomere biology disorders. NPJ Genom Med. 2025. https:\/\/doi.org\/10.1038\/s41525-025-00501-8.","journal-title":"NPJ Genom Med"},{"key":"777_CR132","doi-asserted-by":"publisher","unstructured":"M L, Y Y, Y A, et al. Somatic mutations in telomerase promoter counterbalance germline loss-of-function mutations - PubMed. J Clin Investig. 2017;127(3). https:\/\/doi.org\/10.1172\/JCI91161.","DOI":"10.1172\/JCI91161"},{"key":"777_CR133","doi-asserted-by":"publisher","DOI":"10.1007\/s00439-008-0576-7","author":"E Tsangaris","year":"2008","unstructured":"Tsangaris E, Adams S-L, Yoon G, et al. Ataxia and pancytopenia caused by a mutation in TINF2. Hum Genet. 2008. https:\/\/doi.org\/10.1007\/s00439-008-0576-7.","journal-title":"Hum Genet"},{"key":"777_CR134","doi-asserted-by":"publisher","DOI":"10.1378\/chest.14-1947","author":"JK Alder","year":"2015","unstructured":"Alder JK, Stanley SE, Wagner CL, Hamilton M, Hanumanthu VS, Armanios M. Exome sequencing identifies mutant TINF2 in a family with pulmonary fibrosis. Chest. 2015. https:\/\/doi.org\/10.1378\/chest.14-1947.","journal-title":"Chest"},{"key":"777_CR135","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajhg.2007.10.004","author":"SA Savage","year":"2008","unstructured":"Savage SA, Giri N, Baerlocher GM, Orr N, Lansdorp PM, Alter BP. TINF2, a component of the shelterin telomere protection complex, is mutated in dyskeratosis congenita. Am J Hum Genet. 2008. https:\/\/doi.org\/10.1016\/j.ajhg.2007.10.004.","journal-title":"Am J Hum Genet"},{"key":"777_CR136","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-05-153445","author":"AJ Walne","year":"2008","unstructured":"Walne AJ, Vulliamy T, Beswick R, Kirwan M, Dokal I. TINF2 mutations result in very short telomeres: analysis of a large cohort of patients with dyskeratosis congenita and related bone marrow failure syndromes. Blood. 2008. https:\/\/doi.org\/10.1182\/blood-2008-05-153445.","journal-title":"Blood"},{"key":"777_CR137","doi-asserted-by":"publisher","DOI":"10.1111\/j.1399-0004.2011.01658.x","author":"G Sasa","year":"2012","unstructured":"Sasa G, Ribes-Zamora A, Nelson N, Bertuch A. Three novel truncating TINF2 mutations causing severe dyskeratosis congenita in early childhood. Clin Genet. 2012. https:\/\/doi.org\/10.1111\/j.1399-0004.2011.01658.x.","journal-title":"Clin Genet"},{"key":"777_CR138","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.22624","author":"N Sarper","year":"2010","unstructured":"Sarper N, Zengin E, K\u0131l\u0131\u00e7 S\u00c7. A child with severe form of dyskeratosis congenita and TINF2 mutation of shelterin complex. Pediatr Blood Cancer. 2010. https:\/\/doi.org\/10.1002\/pbc.22624.","journal-title":"Pediatr Blood Cancer"},{"key":"777_CR139","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12088","author":"M Gleeson","year":"2012","unstructured":"Gleeson M, O\u2019Marcaigh A, Cotter M, Brosnahan D, Vulliamy T, Smith OP. Retinal vasculopathy in autosomal dominant dyskeratosis congenita due to TINF2 mutation. Br J Haematol. 2012. https:\/\/doi.org\/10.1111\/bjh.12088.","journal-title":"Br J Haematol"},{"key":"777_CR140","doi-asserted-by":"publisher","DOI":"10.1159\/000439042","author":"B Panichareon","year":"2015","unstructured":"Panichareon B, Seedapan T, Thongnoppakhun W, Limwongse C, Pithukpakorn M, Limjindaporn T. Novel mutation of the TINF2 gene in a patient with dyskeratosis congenita. Case Rep Dermatol. 2015. https:\/\/doi.org\/10.1159\/000439042.","journal-title":"Case Rep Dermatol"},{"key":"777_CR141","doi-asserted-by":"publisher","DOI":"10.1080\/13816810.2016.1275019","author":"MP Gupta","year":"2017","unstructured":"Gupta MP, Talcott KE, Kim DY, Agarwal S, Mukai S. Retinal findings and a novel TINF2 mutation in Revesz syndrome: clinical and molecular correlations with pediatric retinal vasculopathies. Ophthalmic Genet. 2017. https:\/\/doi.org\/10.1080\/13816810.2016.1275019.","journal-title":"Ophthalmic Genet"},{"key":"777_CR142","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2017.04.016","author":"K Moussa","year":"2017","unstructured":"Moussa K, Huang JN, Moore AT. Revesz syndrome masquerading as traumatic retinal detachment. J AAPOS. 2017. https:\/\/doi.org\/10.1016\/j.jaapos.2017.04.016.","journal-title":"J AAPOS"},{"key":"777_CR143","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.27557","author":"A Sakwit","year":"2019","unstructured":"Sakwit A, Rojanaporn D, Mekjaruskul P, Suriyajakryuththana W, Sasanakul W, Sirachainan N. Novel mutation of the TINF2 gene resulting in severe phenotypic Revesz syndrome. Pediatr Blood Cancer. 2019. https:\/\/doi.org\/10.1002\/pbc.27557.","journal-title":"Pediatr Blood Cancer"},{"key":"777_CR144","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaapos.2013.07.016","author":"EM McElnea","year":"2013","unstructured":"McElnea EM, Spek N, Smith O, Fitzsimon S, Patel CK, O\u2019Marcaigh A. Revesz syndrome masquerading as bilateral cicatricial retinopathy of prematurity. J AAPOS. 2013. https:\/\/doi.org\/10.1016\/j.jaapos.2013.07.016.","journal-title":"J AAPOS"},{"key":"777_CR145","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000010724","author":"H Du","year":"2018","unstructured":"Du H, Guo Y, Ma D, et al. A case report of heterozygous TINF2 gene mutation associated with pulmonary fibrosis in a patient with dyskeratosis congenita. Medicine (Baltimore). 2018. https:\/\/doi.org\/10.1097\/MD.0000000000010724.","journal-title":"Medicine (Baltimore)"},{"key":"777_CR146","doi-asserted-by":"publisher","DOI":"10.1016\/j.ehpc.2021.200517","author":"CM Roake","year":"2021","unstructured":"Roake CM, Juntilla M, Agarwal-Hashmi R, Artandi S, Kuo CS. Tissue-specific telomere shortening and degenerative changes in a patient with TINF2 mutation and dyskeratosis congenita. Hum Pathology: Case Rep. 2021. https:\/\/doi.org\/10.1016\/j.ehpc.2021.200517.","journal-title":"Hum Pathology: Case Rep"},{"key":"777_CR147","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.09.043","author":"F Touzot","year":"2012","unstructured":"Touzot F, Gaillard L, Vasquez N, et al. Heterogeneous telomere defects in patients with severe forms of dyskeratosis congenita. J Allergy Clin Immunol. 2012. https:\/\/doi.org\/10.1016\/j.jaci.2011.09.043.","journal-title":"J Allergy Clin Immunol"},{"key":"777_CR148","doi-asserted-by":"publisher","DOI":"10.1101\/gad.2006411","author":"F Zhong","year":"2011","unstructured":"Zhong F, Savage SA, Shkreli M, et al. Disruption of telomerase trafficking by TCAB1 mutation causes dyskeratosis congenita. Genes Dev. 2011. https:\/\/doi.org\/10.1101\/gad.2006411.","journal-title":"Genes Dev"},{"key":"777_CR149","doi-asserted-by":"publisher","DOI":"10.1186\/s12881-018-0549-1","author":"Y Shao","year":"2018","unstructured":"Shao Y, Feng S, Huang J, et al. A unique homozygous WRAP53 Arg298Trp mutation underlies dyskeratosis congenita in a Chinese Han family. BMC Medical Genetics 2018 19:1. 2018. https:\/\/doi.org\/10.1186\/s12881-018-0549-1.","journal-title":"BMC Medical Genetics 2018 19:1"},{"key":"777_CR150","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-020-2421-4","author":"S Bergstrand","year":"2020","unstructured":"Bergstrand S, B\u00f6hm S, Malmgren H, et al. Biallelic mutations in WRAP53 result in dysfunctional telomeres, Cajal bodies and DNA repair, thereby causing Hoyeraal\u2013Hreidarsson syndrome. Cell Death & Disease 2020 11:4. 2020. https:\/\/doi.org\/10.1038\/s41419-020-2421-4.","journal-title":"Cell Death & Disease 2020 11:4"},{"key":"777_CR151","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-021-04678-7","author":"E Brailovski","year":"2021","unstructured":"Brailovski E, Tsui H, Chen Y-B, et al. Previously unreported WRAP53 gene variants in a patient with dyskeratosis congenita. Annals of Hematology 2021 101:4. 2021. https:\/\/doi.org\/10.1007\/s00277-021-04678-7.","journal-title":"Annals of Hematology 2021 101:4"},{"key":"777_CR152","doi-asserted-by":"publisher","unstructured":"S DT FD. NF D, Somatic genetic rescue in ZCCHC8-associated telomere biology disorders - PubMed. Blood 2025.\u00a0https:\/\/doi.org\/10.1182\/blood.2025031248","DOI":"10.1182\/blood.2025031248"},{"key":"777_CR153","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00487-2023","author":"K Groen","year":"2024","unstructured":"Groen K, Vis JJ, Batenburg AA, et al. A new variant in the ZCCHC8 gene: diverse clinical phenotypes and expression in the lung. ERJ Open Res. 2024. https:\/\/doi.org\/10.1183\/23120541.00487-2023.","journal-title":"ERJ Open Res"},{"key":"777_CR154","doi-asserted-by":"publisher","DOI":"10.1101\/gad.326785.119","author":"DL Gable","year":"2019","unstructured":"Gable DL, Gaysinskaya V, Atik CC, et al. ZCCHC8, the nuclear exosome targeting component, is mutated in familial pulmonary fibrosis and is required for telomerase RNA maturation. Genes Dev. 2019. https:\/\/doi.org\/10.1101\/gad.326785.119.","journal-title":"Genes Dev"},{"key":"777_CR155","doi-asserted-by":"publisher","DOI":"10.1111\/cge.14534","author":"NJ Nitschke","year":"2024","unstructured":"Nitschke NJ, Jelsig AM, Lautrup C, et al. Expanding the understanding of telomere biology disorder with reports from two families harboring variants in ZCCHC8 and TERC. Clin Genet. 2024. https:\/\/doi.org\/10.1111\/cge.14534.","journal-title":"Clin Genet"},{"key":"777_CR156","doi-asserted-by":"publisher","DOI":"10.1182\/hematology.2023000490","author":"MR Niewisch","year":"2023","unstructured":"Niewisch MR, Beier F, Savage SA. Clinical manifestations of telomere biology disorders in adults. Hematology. 2023. https:\/\/doi.org\/10.1182\/hematology.2023000490.","journal-title":"Hematology"},{"key":"777_CR157","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.50111","author":"MR Niewisch","year":"2024","unstructured":"Niewisch MR, Kim J, Giri N, Lunger JC, McReynolds LJ, Savage SA. Genotype and associated cancer risk in individuals with telomere biology disorders. JAMA Netw Open. 2024. https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.50111.","journal-title":"JAMA Netw Open"},{"key":"777_CR158","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019003264","author":"KE Schratz","year":"2020","unstructured":"Schratz KE, Haley L, Danoff SK, et al. Cancer spectrum and outcomes in the Mendelian short telomere syndromes. Blood. 2020. https:\/\/doi.org\/10.1182\/blood.2019003264.","journal-title":"Blood"},{"key":"777_CR159","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.178111","author":"BP Alter","year":"2017","unstructured":"Alter BP, Giri N, Savage SA, Rosenberg PS. Cancer in the National Cancer Institute inherited bone marrow failure syndrome cohort after fifteen years of follow-up. Haematologica. 2017. https:\/\/doi.org\/10.3324\/haematol.2017.178111.","journal-title":"Haematologica"},{"key":"777_CR160","doi-asserted-by":"publisher","DOI":"10.1172\/JCI181659","author":"CM Sande","year":"2025","unstructured":"Sande CM, Chen S, Mitchell DV, et al. ATM-dependent DNA damage response constrains cell growth and drives clonal hematopoiesis in telomere biology disorders. J Clin Invest. 2025. https:\/\/doi.org\/10.1172\/JCI181659.","journal-title":"J Clin Invest"},{"key":"777_CR161","doi-asserted-by":"publisher","unstructured":"JC NP. Clonal hematopoiesis in patients with dyskeratosis congenita - PubMed. Am J Hematol. 2016;91(12). https:\/\/doi.org\/10.1002\/ajh.24552.","DOI":"10.1002\/ajh.24552"},{"key":"777_CR162","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2023-190210","author":"F Gutierrez-Rodrigues","year":"2023","unstructured":"Gutierrez-Rodrigues F, Thongon N, Williams CL, Colla S, Young NS, Bertuch AA. Blood count recovery and telomere elongation in a TINF2 patient under treatment with a gonadotropin-releasing hormone (GnRH) agonist. Blood. 2023. https:\/\/doi.org\/10.1182\/blood-2023-190210.","journal-title":"Blood"},{"key":"777_CR163","doi-asserted-by":"publisher","DOI":"10.1172\/JCI147598","author":"KE Schratz","year":"2021","unstructured":"Schratz KE, Gaysinskaya V, Cosner ZL, et al. Somatic reversion impacts myelodysplastic syndromes and acute myeloid leukemia evolution in the short telomere disorders. J Clin Invest. 2021. https:\/\/doi.org\/10.1172\/JCI147598.","journal-title":"J Clin Invest"},{"key":"777_CR164","doi-asserted-by":"publisher","unstructured":"Gutierrez-Rodrigues F, Donaires FS, Pinto A, et al. Pathogenic TERT promoter variants in telomere diseases. Genet Sci. 2018;21(7). https:\/\/doi.org\/10.1038\/s41436-018-0385-x.","DOI":"10.1038\/s41436-018-0385-x"},{"key":"777_CR165","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.201210031","author":"P Kleiblova","year":"2013","unstructured":"Kleiblova P, Shaltiel IA, Benada J, et al. Gain-of-function mutations of PPM1D\/Wip1 impair the p53-dependent G1 checkpoint. J Cell Biol. 2013. https:\/\/doi.org\/10.1083\/jcb.201210031.","journal-title":"J Cell Biol"},{"key":"777_CR166","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023020331","author":"PG Miller","year":"2023","unstructured":"Miller PG, Sperling AS, Mayerhofer C, et al. PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy. Blood. 2023. https:\/\/doi.org\/10.1182\/blood.2023020331.","journal-title":"Blood"},{"key":"777_CR167","doi-asserted-by":"publisher","unstructured":"JA AFTL. Patients with telomere biology disorders show context specific somatic mosaic states with high frequency of U2AF1 variants - PubMed. Am J Hematol. 2023;98(12). https:\/\/doi.org\/10.1002\/ajh.27086.","DOI":"10.1002\/ajh.27086"},{"key":"777_CR168","doi-asserted-by":"publisher","DOI":"10.1038\/nature09787","author":"E Sahin","year":"2011","unstructured":"Sahin E, Colla S, Liesa M. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature. 2011. https:\/\/doi.org\/10.1038\/nature09787.","journal-title":"Nature"},{"key":"777_CR169","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)80762-X","author":"L Chin","year":"1999","unstructured":"Chin L, Artandi SE, Shen Q, et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell. 1999. https:\/\/doi.org\/10.1016\/S0092-8674(00)80762-X.","journal-title":"Cell"},{"key":"777_CR170","doi-asserted-by":"publisher","DOI":"10.1016\/j.stem.2023.01.006","author":"M Sebert","year":"2023","unstructured":"Sebert M, Gachet S, Leblanc T. Clonal hematopoiesis driven by chromosome 1q\/MDM4 trisomy defines a canonical route toward leukemia in Fanconi anemia. Cell Stem Cell. 2023. https:\/\/doi.org\/10.1016\/j.stem.2023.01.006.","journal-title":"Cell Stem Cell"},{"key":"777_CR171","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-822262","author":"T Inaba","year":"2018","unstructured":"Inaba T, Honda H, Matsui H. The enigma of monosomy 7. Blood. 2018. https:\/\/doi.org\/10.1182\/blood-2017-12-822262.","journal-title":"Blood"},{"key":"777_CR172","doi-asserted-by":"publisher","unstructured":"Kotmayer L, Kennedy AL, Wlodarski MW. Germline and somatic genetic landscape of pediatric myelodysplastic syndromes. Haematologica. 2025;110(9). https:\/\/doi.org\/10.3324\/haematol.2024.285700.","DOI":"10.3324\/haematol.2024.285700"},{"key":"777_CR173","doi-asserted-by":"publisher","unstructured":"Killela PJ, Reitman ZJ, Jiao Y, et al. TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal. Proc Natl Acad Sci USA. 2013;110(15). https:\/\/doi.org\/10.1073\/pnas.1303607110.","DOI":"10.1073\/pnas.1303607110"},{"key":"777_CR174","doi-asserted-by":"publisher","DOI":"10.1093\/hmg\/ddad210","author":"A Bertrand","year":"2024","unstructured":"Bertrand A, Ba I, Kermasson L, et al. Characterization of novel mutations in the TEL-patch domain of the telomeric factor TPP1 associated with telomere biology disorders. Hum Mol Genet. 2024. https:\/\/doi.org\/10.1093\/hmg\/ddad210.","journal-title":"Hum Mol Genet"},{"key":"777_CR175","doi-asserted-by":"publisher","DOI":"10.1016\/j.mrrev.2016.11.002","author":"B Heidenreich","year":"2017","unstructured":"Heidenreich B, Kumar R. Tert promoter mutations in telomere biology. Mutat Research\/Reviews Mutat Res. 2017. https:\/\/doi.org\/10.1016\/j.mrrev.2016.11.002.","journal-title":"Mutat Research\/Reviews Mutat Res"},{"key":"777_CR176","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12102739","author":"Y Wu","year":"2020","unstructured":"Wu Y, Poulos RC, Reddel RR. Role of POT1 in human cancer. Cancers. 2020. https:\/\/doi.org\/10.3390\/cancers12102739.","journal-title":"Cancers"},{"key":"777_CR177","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2941","author":"J Shi","year":"2014","unstructured":"Shi J, Yang XR, Ballew B, et al. Rare missense variants in POT1 predispose to familial cutaneous malignant melanoma. Nature Genetics 2014 46:5. 2014. https:\/\/doi.org\/10.1038\/ng.2941.","journal-title":"Nature Genetics 2014 46:5"},{"key":"777_CR178","doi-asserted-by":"publisher","DOI":"10.1038\/ng.2947","author":"CD Robles-Espinoza","year":"2014","unstructured":"Robles-Espinoza CD, Harland M, Ramsay AJ, et al. POT1 loss-of-function variants predispose to familial melanoma. Nat Genet. 2014. https:\/\/doi.org\/10.1038\/ng.2947.","journal-title":"Nat Genet"},{"key":"777_CR179","doi-asserted-by":"publisher","DOI":"10.1007\/s10522-023-10080-9","author":"SA Savage","year":"2023","unstructured":"Savage SA, Savage SA. Telomere length and cancer risk: finding Goldilocks. Biogerontology. 2023. https:\/\/doi.org\/10.1007\/s10522-023-10080-9.","journal-title":"Biogerontology"},{"key":"777_CR180","doi-asserted-by":"publisher","unstructured":"EA D, MG T. KE S, Familial Clonal Hematopoiesis in a Long Telomere Syndrome - PubMed. N Engl J Med\u00a02023;388(26).\u00a0https:\/\/doi.org\/10.1056\/NEJMoa2300503","DOI":"10.1056\/NEJMoa2300503"},{"key":"777_CR181","doi-asserted-by":"publisher","unstructured":"Lim TL, Lieberman DB, Davis AR et al. Germline POT1 variants can predispose to myeloid and lymphoid neoplasms. Leukemia 2021 36:1. 2021;36(1)https:\/\/doi.org\/10.1038\/s41375-021-01335-w","DOI":"10.1038\/s41375-021-01335-w"},{"key":"777_CR182","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkac1269","author":"R Storchova","year":"2023","unstructured":"Storchova R, Palek M, Palkova N. Phosphorylation of TRF2 promotes its interaction with TIN2 and regulates DNA damage response at telomeres. Nucleic Acids Res. 2023. https:\/\/doi.org\/10.1093\/nar\/gkac1269.","journal-title":"Nucleic Acids Res"},{"key":"777_CR183","doi-asserted-by":"crossref","unstructured":"C V. T M, JB H, A practical approach to curate clonal hematopoiesis of indeterminate potential in human genetic data sets - PubMed. Blood. 2023;141(18). doi:10.1182\/blood.2022018825.","DOI":"10.1182\/blood.2022018825"},{"key":"777_CR184","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2025028417","author":"Y Pershad","year":"2025","unstructured":"Pershad Y, Uddin MM, Xue L, et al. Correlates and consequences of clonal hematopoiesis expansion rate: a 16-year longitudinal study of 6,976 women. Blood. 2025. https:\/\/doi.org\/10.1182\/blood.2025028417.","journal-title":"Blood"},{"key":"777_CR185","doi-asserted-by":"publisher","DOI":"10.1038\/s41588-025-02296-x","author":"MA McLoughlin","year":"2025","unstructured":"McLoughlin MA, Cheloor Kovilakam S, Dunn WG. Telomere attrition becomes an instrument for clonal selection in aging hematopoiesis and leukemogenesis. Nature Genetics 2025 57:9. 2025. https:\/\/doi.org\/10.1038\/s41588-025-02296-x.","journal-title":"Nature Genetics 2025 57:9"},{"key":"777_CR186","doi-asserted-by":"publisher","DOI":"10.1016\/j.stemcr.2017.06.015","author":"WC Fok","year":"2017","unstructured":"Fok WC, Niero E, Dege C, Brenner KA, Sturgeon CM, Batista LFZ. P53 mediates failure of human definitive hematopoiesis in dyskeratosis congenita. Stem Cell Rep. 2017. https:\/\/doi.org\/10.1016\/j.stemcr.2017.06.015.","journal-title":"Stem Cell Rep"},{"key":"777_CR187","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.03.005","author":"KE Schratz","year":"2023","unstructured":"Schratz KE, Flasch DA, Atik CC. T cell immune deficiency rather than chromosome instability predisposes patients with short telomere syndromes to squamous cancers. Cancer Cell. 2023. https:\/\/doi.org\/10.1016\/j.ccell.2023.03.005.","journal-title":"Cancer Cell"}],"updated-by":[{"DOI":"10.1007\/s11899-026-00783-4","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T00:00:00Z","timestamp":1783641600000}}],"container-title":["Current Hematologic Malignancy Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-026-00777-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11899-026-00777-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11899-026-00777-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T07:42:37Z","timestamp":1783669357000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11899-026-00777-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,14]]},"references-count":187,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1007\/s11899-026-00777-2","relation":{},"ISSN":["1558-822X"],"issn-type":[{"value":"1558-822X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,14]]},"assertion":[{"value":"5 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2026","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The original online version of this article was revised due to a retrospective Open Access cancellation.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s11899-026-00783-4","URL":"https:\/\/doi.org\/10.1007\/s11899-026-00783-4","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"9"}}